Letter by L. Schlemm and E. Schlemm Regarding Article, “Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity”
Standard
Letter by L. Schlemm and E. Schlemm Regarding Article, “Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity”. / Schlemm, Ludwig; Schlemm, Eckhard.
in: STROKE, 03.02.2020.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Letter by L. Schlemm and E. Schlemm Regarding Article, “Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity”
AU - Schlemm, Ludwig
AU - Schlemm, Eckhard
PY - 2020/2/3
Y1 - 2020/2/3
U2 - https://doi.org/10.1161/STROKEAHA.119.028453
DO - https://doi.org/10.1161/STROKEAHA.119.028453
M3 - Other (editorial matter etc.)
JO - STROKE
JF - STROKE
SN - 0039-2499
ER -